Industry News
Spectrum Pharmaceuticals Appoints New President and COO
Spectrum Pharmaceuticals appoints Joseph Turgeon as president and COO.
Bristol-Myers Squibb and Samsung BioLogics Expand Manufacturing Agreement
Bristol-Myers Squibb and Samsung BioLogics expand their manufacturing agreement to cover biologic medicines.
Eli Lilly's Cyramza Receives FDA Approval for Treatment of Advanced Gastric Cancer
Lilly1s Cyramza is the first FDA-approved treatment for advanced gastric cancer after prior chemotherapy.
Aastrom Biosciences Acquires Sanofi's Cell Therapy and Regenerative Medicine Business
Aastrom Biosciences will acquire Sanofi's CTRM business for $6.5 million.
Novartis's Bexsero Receives FDA Breakthrough Therapy Designation
Novartis receives FDA breakthrough therapy designation for Bexsero, a meningitis B vaccine.
DepoVax Technology Selected for HPV–related Cancer Trials
Immunovaccine's vaccine technology chosen for cervical, head, and neck cancer trials conducted by Dana-Farber Institute.
PolyTherics and MacroGenics Extend ADC Collaboration
ThioBridge linker technology to attach different payloads to a range of antibodies
uniQure Announces Management Changes
uniQure appoints a new COO and vice president, Medical affairs.
Desktop Human Body Developed for Toxicity Testing
The Advanced Tissue-engineered Human Ectypal Network Analyzer project team is developing realistic human organs for testing.
Lilly To Release Data Targeting Key Cancer Pathways At AACR 2014
Eli Lilly will present early-stage data regarding cancer therapies at AACR 2014.
Sun Pharma to Acquire Ranbaxy
Sun Pharma acquisition of Ranbaxy Laboratories will create the fifth-largest specialty generics company in the world.
A New Plant Biotech Approach for Efficient Production of Pharmaceutical Compound
European scientists have discovered a method to improve the efficiency of the pharmaceutical production through plant biotechnology.
Recurrent Head and Neck Tumors Could be Vulnerable to Cancer Drug
New research finds that recurrent head and neck tumors have gene mutations that could be vulnerable to the cancer drug dasatinib.
Immunovaccine Presents New Cancer Vaccine Data at AACR
Immunovaccine reports enhanced cancer vaccine combination therapies at 2014 AACR Annual Meeting.
Genzyme to Resubmit Lemtrada Application for FDA Review
Sanofi and Genzyme to resubmit FDA application for approval of Lemtrada, for the treatment of relapsing forms of multiple sclerosis.
Novartis and Malaria No More Campaign Provide Antimalarial Treatments in Zambia
Novartis delivers 2 million treatments of its pediatric antimalarial to Zambia in collaboration with Malaria No More's Power of One campaign.
Vetter Implements New Serialization Services
Vetter launches new serialization process to support track-and-trace efforts.
Regulatory Compliance Associates Expands into Poland
RCA opens a new office in Warsaw, Poland.
XstalBio Launches Vaccine Analysis Service
XstalBio Analytics' approach to vaccine analysis and formulation is aimed at understanding the antigen– adjuvant interaction.
FDA approves Novartis' Xolair for Rare Skin Disease
FDA approves Xolair (omalizumab) for the treatment of a rare skin disease known as chronic idiopathic urticarial.
Texas A&M Center Adds Mobile Cleanrooms
Walker Barrier Systems builds eight mobile clean rooms for the Texas A&M Center for Innovation in Advanced Development and Manufacturing.
DPx Launched as Provider of Pharmaceutical Services, Fine Chemicals, and Proprietary Technologies
$2.6 billion transaction combines Patheon and DSM Pharmaceutical to create CDMO, DPx.
Almac Expands Asia Pacific Operations
Almac expands technical, project, and operational resources in Asia.
Johnson Controls Launches Integrated Laboratory Services
Johnson Controls launches Integrated Laboratory Services for R&D facility operations and scientific productivity.
CPhI Report Shows R&D Market Diversifying
CPhI report shows R&D market diversifying with increased partnerships, mergers, and revenue sharing models.
Cobra Biologics and BioCancell Collaborate on Cancer Therapy Drug
Cobra Biologics and BioCancell announce an agreement to manufacture BioCancell's BC-821 cancer drug.
Waters Marks Ten Years of ACQUITY UPLC With the Introduction of New Products
Waters celebrates ten&$45;year anniversary of the ACQUITY UPLC System.
FDA Approves Orphan Drug Myalept
FDA approves the orphan drug Myalept for the treatment of leptin deficiency.
UC Santa Barbara Students Get Bexsero to Treat Meningitis B
Novartis provides its second US university with Bexsero for the treatment of meningitis B.
Elanco to Acquire Lohmann Animal Health
Elanco acquires Germany-based Lohmann Animal Health.
